Aspire Biopharma Holdings, Inc. (ASBP) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US7389203057
Aspire Biopharma Holdings, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 6,202.00 USD |
| Gross profit | -116.00 USD |
| Operating income | -19.35 m USD |
| EBIT | -15.95 m USD |
| Net income | -24.48 m USD |
| Diluted EPS – continuing operations | -16.38 USD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
More stocks
- Adia Nutrition, Inc. (ADIA)
- MANNATECH INC (MTEX)
- AQUABOUNTY TECHNOLOGIES INC (AQB)
- BLOOMIA HOLDINGS, INC. (TULP)
- Awaysis Capital, Inc. (AWCA)
- KIDOZ INC. (KDOZF)
- Granite Point Mortgage Trust Inc. (GPMT)
- Smartbird, Inc. (BIRD)
- CARVER BANCORP INC (CARV)
- TAITRON COMPONENTS INC (TAIT)
- Lifeward Ltd. (LFWD)
- GLEN BURNIE BANCORP (GLBZ)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.